<?xml version="1.0" encoding="UTF-8"?>
<ref id="B136-pharmaceuticals-12-00147">
 <label>136.</label>
 <element-citation publication-type="journal">
  <person-group person-group-type="author">
   <name>
    <surname>Arns</surname>
    <given-names>S.</given-names>
   </name>
   <name>
    <surname>Balgi</surname>
    <given-names>A.D.</given-names>
   </name>
   <name>
    <surname>Shimizu</surname>
    <given-names>Y.</given-names>
   </name>
   <name>
    <surname>Pfeifer</surname>
    <given-names>T.A.</given-names>
   </name>
   <name>
    <surname>Kumar</surname>
    <given-names>N.</given-names>
   </name>
   <name>
    <surname>Shidmoossavee</surname>
    <given-names>F.S.</given-names>
   </name>
   <name>
    <surname>Sun</surname>
    <given-names>S.</given-names>
   </name>
   <name>
    <surname>Tai</surname>
    <given-names>S.S.H.</given-names>
   </name>
   <name>
    <surname>Agafitei</surname>
    <given-names>O.</given-names>
   </name>
   <name>
    <surname>Jaquith</surname>
    <given-names>J.B.</given-names>
   </name>
   <etal/>
  </person-group>
  <article-title>Novel spirothiazamenthane inhibitors of the influenza A M2 proton channel</article-title>
  <source>Eur. J. Med. Chem.</source>
  <year>2016</year>
  <volume>120</volume>
  <fpage>64</fpage>
  <lpage>73</lpage>
  <pub-id pub-id-type="doi">10.1016/j.ejmech.2016.05.008</pub-id>
  <?supplied-pmid 27187859?>
  <pub-id pub-id-type="pmid">27187859</pub-id>
 </element-citation>
</ref>
